Diabetes
-
HCCI Spotlights National Diabetes Month: ESI Enrollees with Diabetes Face High Out-of-Pocket Costs. A Cap on Insulin Costs Would Help Many.
Read more: HCCI Spotlights National Diabetes Month: ESI Enrollees with Diabetes Face High Out-of-Pocket Costs. A Cap on Insulin Costs Would Help Many.Diabetes is a chronic health condition that affects over 10% of the U.S. population. It is possible for people who are diagnosed with diabetes to live a healthy, long life if the condition is managed properly. However, management often involves significant health care use, which can be costly for patients. Over the past few months, we used HCCI’s…
-
Over 50% of Insulin Users with ESI Spend over $35 Out-of-pocket on 30-day Supply of Insulin
Read more: Over 50% of Insulin Users with ESI Spend over $35 Out-of-pocket on 30-day Supply of InsulinPreviously, HCCI analyzed prescription drug spending to understand how many insulin users with employer sponsored insurance (ESI) would be affected by a $35 monthly cap on patient out-of-pocket spending on insulin. Our estimates were based on average monthly out-of-pocket spending on insulin across all insulin products. The Inflation Reduction Act (IRA) recently passed by Congress…
-
Privately Insured Individuals with Diabetes Spend Twice as Much Out-of-Pocket on Health Care as those without Diabetes
Read more: Privately Insured Individuals with Diabetes Spend Twice as Much Out-of-Pocket on Health Care as those without DiabetesOver 10% of the U.S. population— more than 34 million individuals— lives with diabetes, with 1.5 million new cases diagnosed each year. As people with diabetes manage this chronic condition, they often pay substantial amounts out of their own pockets on medical care and prescription medications. Using HCCI’s unique health care claims dataset, this brief…
-
Insulin Use Explains Variation in Level, but not Growth, of Out-of-Pocket Spending on Insulin Products
Read more: Insulin Use Explains Variation in Level, but not Growth, of Out-of-Pocket Spending on Insulin ProductsWe previously published two blogs discussing trends in out-of-pocket spending on insulin products. First, we presented data illustrating how average monthly out-of-pocket spending in 2017 varied considerably by month, particularly for individuals enrolled in consumer-directed health plans (CDHPs) that carry higher deductibles. Second, we examined the relationship between increasing point-of-sale prices between 2012 and 2017…
-
Rising Point-of-Sale Prices for Insulin Correspond with Higher Out-of-Pocket Spending on Insulin in January
Read more: Rising Point-of-Sale Prices for Insulin Correspond with Higher Out-of-Pocket Spending on Insulin in JanuaryEarlier this week we presented data on out-of-pocket spending on insulin during each month in 2017. In that blog, we showed that enrollees in employer-sponsored health insurance paid more out-of-pocket for insulin products at the beginning of the calendar year. We examined the relationship between increasing point-of-sale prices for insulin and higher out-of-pocket spending in…
-
Out-of-Pocket Spending on Insulin is Highest at the Beginning of the Year
Tags: Commercially Insured, Consumer-Directed Health Plans, Diabetes, Drug Spending, Geographic Variation, Insulin
Read more: Out-of-Pocket Spending on Insulin is Highest at the Beginning of the YearPeople who get health insurance through their jobs pay more than twice as much for insulin at the beginning of the year than they do at the end of the year, on average. New analysis of HCCI data shows that, nationally, in January 2017, average out-of-pocket spending on insulin was $105. This spending declined every…
-
Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin Prices
Read more: Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin PricesWe used health care claims data to investigate trends in total health care spending on individuals with type 1 diabetes between 2012 and 2016. We found a rapid increase in total health care spending, driven primarily by gross spending on insulin that doubled over the period. During that time insulin use rose only modestly. While…
-
Price of insulin prescription doubled between 2012 and 2016
Read more: Price of insulin prescription doubled between 2012 and 2016In honor of National Diabetes Month, our inaugural blog post focuses on a topic of particular interest to people with diabetes: the price of insulin. Insulin is the hormone responsible for the body’s ability to use sugar and prevent dangerously high and potentially deadly levels of blood sugar. Diabetics are unable to make enough insulin…
-
2014 Diabetes Health Care Cost and Utilization Report
Read more: 2014 Diabetes Health Care Cost and Utilization ReportThe 2014 Diabetes Health Care Cost and Utilization Report examines how much is spent on health care for adults and children with diabetes, where those dollars are spent, and how that compares to people without diabetes. It is based on the health care claims of more than 40 million Americans younger than 65 covered by…
-
The Price-Quality Paradox in Health Care
Read more: The Price-Quality Paradox in Health CareThis data brief compares average state-level prices against quality measures for asthma, diabetes and hypertension care and finds that higher prices for medical services are not always indicative of higher quality of care.